In theory, the continuous subcutaneous insulin infusion (CSII) has a few advantages over
the multiple daily insulin injections (MDI) that should lead to improved glycemic control and …

Restoration of the physiological insulin secretion is a current medical challenge and a
dream for patients with Diabetes Mellitus. Continuous insulin therapy using pumps was the …

Abstract Background and aim: Continuous Subcutaneous Insulin Infusion (CSII) and Multiple
Daily insulin Injections (MDI) are both strategies aiming to achieve a tight glycemic and …

The aim of diabetes treatment is to achieve tight glucose control to avoid the development of
chronic diabetic complications while reducing the frequency of hypoglycaemic episodes …

Continuous subcutaneous insulin infusion (CSII) continues to be a popular mechanism for
insulin delivery for selected patients with insulin-dependent diabetes mellitus. The major …

Before the initiation of insulin pump therapy, patients must be aware of the different aspects
of this form of intensive insulin therapy. Most healthcare professionals recommend a …

Background Intensive insulin therapy should be proposed for most type 1 diabetic patients. It
can be achieved by a continuous subcutaneous insulin infusion (CSII) or by multiple daily …

Diabetes is recognized as one of the most severe health problem in the world. It spares no
one, attacking men, women, children, and the elderly. Diabetes is the leading cause of …

Achieving optimal glucose control with minimal hypoglycemia and minimizing the impact of
diabetes on quality of life are the aims of management of type 1 diabetes. The main …

Continuous subcutaneous insulin infusion (CSII) for type 2 diabetes mellitus (T2DM) is a
promising therapy, but the clinical evidence supporting it is mixed. Large randomized …